{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:59:56Z","timestamp":1787979596574,"version":"build-2784847793"},"reference-count":11,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,3,20]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>We report the case of a man in his late 30s who presented with a history of breathlessness and cough with haemoptysis. Complete blood counts revealed pancytopenia. High-resolution CT showed diffuse bilateral ground glass opacities. Sequential bronchoalveolar lavage confirmed alveolar haemorrhage. Bone marrow aspiration showed vacuoles in erythroid and myeloid precursor cells. The genome was sequenced, and the UBA1 gene revealed a c.121 A&gt;G mutation (p.Met41Val), confirming vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. The patient was managed with high-dose prednisolone pulse therapy. He improved with the complete resolution of the alveolar haemorrhage and an improvement in lung function and cytopenias.<\/jats:p>","DOI":"10.1136\/bcr-2023-259474","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:22:23Z","timestamp":1711549343000},"page":"e259474","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["VEXAS syndrome presenting as diffuse alveolar haemorrhage"],"prefix":"10.1136","volume":"17","author":[{"given":"Fayaz Ahmad","family":"Sofi","sequence":"first","affiliation":[{"name":"General Medicine, Division of Rheumatology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu & Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaariq Mehraj","family":"Naqati","sequence":"additional","affiliation":[{"name":"General Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu & Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq","family":"Ahmad","sequence":"additional","affiliation":[{"name":"General Medicine, Division of Rheumatology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu & Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffar","family":"Bindroo","sequence":"additional","affiliation":[{"name":"General Medicine, Division of Rheumatology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu & Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"2025082711262214000_17.3.e259474.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026834"},{"key":"2025082711262214000_17.3.e259474.2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00296-022-05266-2","article-title":"Pulmonary manifestations in VEXAS (Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review","volume":"43","author":"Kouranloo","year":"2023","journal-title":"Rheumatol Int"},{"key":"2025082711262214000_17.3.e259474.3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.chest.2022.10.011","article-title":"Pleuropulmonary manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome","volume":"163","author":"Borie","year":"2023","journal-title":"CHEST"},{"key":"2025082711262214000_17.3.e259474.4","doi-asserted-by":"crossref","first-page":"108996","DOI":"10.1016\/j.clim.2022.108996","article-title":"Beh\u00e7et\u2019s disease with a somatic UBA1 variant:expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome","volume":"238","author":"Matsumoto","year":"2022","journal-title":"Clin Immunol"},{"key":"2025082711262214000_17.3.e259474.5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.41957","article-title":"VEXAS syndrome with systemic lupus erythematosus: expanding the spectrum of associated conditions","volume":"74","author":"Sharma","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025082711262214000_17.3.e259474.6","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/rheumatology\/keab782","article-title":"VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin a vasculitis","volume":"61","author":"P\u00e0mies","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025082711262214000_17.3.e259474.7","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1093\/rheumatology\/keab200","article-title":"A case of VEXAS syndrome manifesting as kikuchi-fujimoto disease, relapsing polychondritis, venous thromboembolism and macrocytic anaemia","volume":"60","author":"Lee","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025082711262214000_17.3.e259474.8","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/rheumatology\/keab683","article-title":"VEXAS syndrome-related AA amyloidosis: a case report","volume":"61","author":"Euvrard","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025082711262214000_17.3.e259474.9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood.2022016642","article-title":"Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study","volume":"140","author":"Heiblig","year":"2022","journal-title":"Blood"},{"key":"2025082711262214000_17.3.e259474.10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.901063","article-title":"Case report: tocilizumab treatment for VEXAS syndrome with relapsing polychondritis: a single-center, 1-year longitudinal observational study in Japan","volume":"13","author":"Kunishita","year":"2022","journal-title":"Front Immunol"},{"key":"2025082711262214000_17.3.e259474.11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1182\/bloodadvances.2021004749","article-title":"Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience","volume":"6","author":"Diarra","year":"2022","journal-title":"Blood Adv"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-259474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:26:28Z","timestamp":1756319188000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-259474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,27]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bcr-2023-259474"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-259474","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}